Skip to main content

Drug Repurposing mittels künstlicher Intelligenz

  • Chapter
  • First Online:
Handbuch Digitale Gesundheitswirtschaft
  • 1461 Accesses

Zusammenfassung

Drug Repurposing (DR) beschreibt die Suche nach neuen therapeutischen Einsatzmöglichkeiten für bereits zugelassene Arzneimittel. Doch wie können entsprechende Hypothesen mittels bereits bestehenden Daten formuliert werden?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Jarada TN, Rokne JG, Alhajj R. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. Journal of cheminformatics. 2020;12(1):1–23.

    Google Scholar 

  2. Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nature reviews Drug discovery. 2019;18(1):41–58.

    Google Scholar 

  3. Ledford H. Dozens of coronavirus drugs are in development – what happens next? Nature. 2020;581(7808):247–9.

    Google Scholar 

  4. DiMasi JA. Risks in new drug development: approval success rates for investigational drugs. Clinical Pharmacology & Therapeutics. 2001;69(5):297–307.

    Google Scholar 

  5. Serafin MB, Bottega A, Foletto VS, da Rosa TF, Hörner A, Hörner R. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents. 2020;55(6):105969.

    Google Scholar 

  6. Harris M, Bhatti Y, Buckley J, Sharma D. Fast and frugal innovations in response to the COVID-19 pandemic. Nature Medicine. 2020;26(6):814–7.

    Google Scholar 

  7. Zhu F, Patumcharoenpol P, Zhang C, Yang Y, Chan J, Meechai A, et al. Biomedical text mining and its applications in cancer research. Journal of biomedical informatics. 2013;46(2):200–11.

    Google Scholar 

  8. Han P, Yang P, Zhao P, Shang S, Liu Y, Zhou J, et al., editors. GCN-MF: disease-gene association identification by graph convolutional networks and matrix factorization. Proceedings of the 25th ACM SIGKDD international conference on knowledge discovery & data mining; 2019

    Google Scholar 

  9. Nugent T, Plachouras V, Leidner JL. Computational drug repositioning based on side-effects mined from social media. PeerJ Computer Science. 2016;2:e46.

    Google Scholar 

  10. Udrescu L, Sbârcea L, Topîrceanu A, Iovanovici A, Kurunczi L, Bogdan P, et al. Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing. Scientific reports. 2016;6(1):1–10.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan Koß .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer Fachmedien Wiesbaden GmbH, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Koß, J. (2023). Drug Repurposing mittels künstlicher Intelligenz. In: Bohnet-Joschko, S., Pilgrim, K. (eds) Handbuch Digitale Gesundheitswirtschaft . Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-41781-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-658-41781-9_19

  • Published:

  • Publisher Name: Springer Gabler, Wiesbaden

  • Print ISBN: 978-3-658-41780-2

  • Online ISBN: 978-3-658-41781-9

  • eBook Packages: Business and Economics (German Language)

Publish with us

Policies and ethics